Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Appointed director
CC transcript
|
|
ENZO BIOCHEM INC (ENZ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2023 |
8-K/A
| Quarterly results |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/17/2023 |
8-K
| Other Events Interactive Data |
| 07/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 06/16/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/08/2023 |
8-K
| Other Events Interactive Data |
| 04/13/2023 |
8-K
| Quarterly results |
| 04/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 03/16/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 02/03/2023 |
8-K
| Quarterly results |
| 11/03/2022 |
8-K
| Quarterly results |
| 10/20/2022 |
8-K
| Quarterly results |
| 05/06/2022 |
8-K/A
| Quarterly results |
| 04/27/2022 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 04/08/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 03/30/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"*** 12 You acknowledge and agree that you have read and understand this Employment agreement and you voluntarily agree to the terms and conditions contained herein. We look forward to you joining the Company. If you accept this offer of employment, please sign and return to me this Employment Agreement attached by no later than March 27, 2022 or this offer shall expire.",
"EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement , dated as of March 24, 2022, made between Enzo Biochem, Inc., a New York corporation, with its principal office at 527 Madison Avenue, New York, New York 10022 and Kara Cannon . Whereas, Executive is currently a full-time employee of the Company; and Whereas, the Company desires for Executive to continue to provide services to the Company, and wishes to provide Executive with certain compensation and benefits in return for such employment services; and Whereas, Executive wishes to continue to be employed by the Company and to provide personal services to the Company in return for certain compensation and benefits; Now, Therefore, in consideration of the mutual promises and covenants contained herein and for other good and ...",
"First Amended and Restated Employment Agreement between Enzo Biochem, Inc. and Hamid Erfanian, effective as of March 24, 2022",
"Enzo Biochem Announces Appointments of David Bench and Kara Cannon to New Executive Management Positions" |
|
| 03/18/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 03/07/2022 |
8-K
| Quarterly results |
| 01/21/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/04/2022 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 10/18/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/14/2021 |
8-K
| Quarterly results |
| 06/11/2021 |
8-K
| Quarterly results |
| 03/19/2021 |
8-K
| Quarterly results |
| 03/16/2021 |
8-K
| Quarterly results |
| 01/08/2021 |
8-K
| Quarterly results |
| 01/06/2021 |
8-K
| Investor presentation |
| 12/17/2020 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 12/14/2020 |
8-K
| Quarterly results |
| 11/25/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS , November 25, 2020 – Enzo Biochem, Inc. , a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has been appointed to the Company’ s Board of Directors effective immediately. Dr. Walters is an experienced entrepreneur and drug developer with leadership in the development of over 30 drugs in multiple therapeutic areas involving diverse technologies, leading to five new oncology drug approvals. His previous positions include Executive Director of Global Oncology Clinical Research and Business Development for Bristol-Myers Squibb, and Medical Director at Millennium Pharmaceuticals. Dr. Walters currently is CEO and Director of Portage Biotech, a publicly traded clinical stage ..." |
|
| 11/23/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/16/2020 |
8-K
| Resignation/termination of a director |
| 06/25/2020 |
8-K
| Quarterly results |
| 06/08/2020 |
8-K
| Quarterly results |
|
|
|